← Back to APGE

Apogee Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 10/08/2026Mar 2026Filed 10/08/2026Sep 2025Filed 10/11/2025Jun 2025Filed 10/08/2026Mar 2025Filed 10/08/2026Sep 2024Filed 10/11/2025Jun 2024Filed 10/11/2025Mar 2024Filed 10/11/2025
−$86−$74−$65−$66−$55−$49−$34−$32
−$1.14−$1.06−$1.11−$1.13−$0.95−$0.86−$0.60−$0.64
7570595858575750

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.